⌘K

Home/Filings/4/0001144204-18-060325

4//SEC Filing

Dallas Matthew D 4

Accession 0001144204-18-060325

CIK 0001563665other

View on SEC.gov Company Profile

Filed

Nov 14, 7:00 PM ET

Accepted

Nov 15, 7:06 PM ET

Size

5.5 KB

Accession

0001144204-18-060325

Insider Transaction Report

Form 4

Period: 2018-11-13

Biostage, Inc.BSTG

Dallas Matthew D

Director

Transactions

Award
Stock Option (right to buy)
2018-11-13+10,897→ 10,897 total
Exercise: $2.75Exp: 2028-11-13→ Common Stock, par value $0.01 per share (10,897 underlying)

Footnotes (1)

[F1]The Stock Option shares will vest in four equal installments on February 13, 2019, May 13, 2019, August 13, 2019, and November 13, 2019.

Documents

1 file

4
tv507434_form4.xmlPrimary
FORM 4

Issuer

Biostage, Inc.

CIK 0001563665

Entity typeother

Related Parties

1

filerCIK 0001612396

Filing Metadata

Form type: 4
Filed: Nov 14, 7:00 PM ET
Accepted: Nov 15, 7:06 PM ET
Size: 5.5 KB

View on SEC.gov